KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Inventory Average: 2018-2025

Historic Inventory Average for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to $611.7 million.

  • Amneal Pharmaceuticals' Inventory Average rose 4.39% to $611.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $611.7 million, marking a year-over-year increase of 4.39%. This contributed to the annual value of $596.9 million for FY2024, which is 7.35% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Inventory Average stood at $611.7 million for Q3 2025, which was up 1.08% from $605.2 million recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Inventory Average peaked at $611.7 million during Q3 2025, and registered a low of $493.8 million during Q1 2021.
  • For the 3-year period, Amneal Pharmaceuticals' Inventory Average averaged around $579.6 million, with its median value being $578.9 million (2023).
  • Data for Amneal Pharmaceuticals' Inventory Average shows a peak YoY increased of 20.59% (in 2021) over the last 5 years.
  • Amneal Pharmaceuticals' Inventory Average (Quarterly) stood at $504.8 million in 2021, then rose by 6.43% to $537.3 million in 2022, then grew by 7.75% to $578.9 million in 2023, then grew by 4.40% to $604.4 million in 2024, then rose by 4.39% to $611.7 million in 2025.
  • Its Inventory Average was $611.7 million in Q3 2025, compared to $605.2 million in Q2 2025 and $606.9 million in Q1 2025.